There are 304 resources available
Invited Discussant 118O, LBA2 and LBA 3
Presenter: Rolf Stahel
Session: Proffered Paper session 1
Resources:
Slides
Webcast
T cell-based immunotherapy for malignant glioma
Presenter: Hideho Okada
Session: The future of CNS tumors: Learning from failures and driven by biology
Resources:
Slides
Webcast
64O - Lenvatinib plus pembrolizumab, pemetrexed, and a platinum (len + pembro + chemo) as first-line therapy for metastatic nonsquamous non-small cell lung cancer (NSCLC): phase 3 LEAP-006 study
Presenter: Roy S. Herbst
Session: Proffered Paper session 1
Resources:
Abstract
Slides
Webcast
Q&A and discussion
Presenter: All Speakers
Session: Leveraging insights from basic cancer immunology for translation
Resources:
Webcast
Q&A and discussion
Presenter: All Speakers
Session: The future of CNS tumors: Learning from failures and driven by biology
Resources:
Webcast
65O - Phase 3 LEAP-008 study of lenvatinib plus pembrolizumab versus docetaxel for metastatic non-small cell lung cancer (NSCLC) that progressed on a PD-(L)1 inhibitor and platinum-containing chemotherapy
Presenter: Natasha Leighl
Session: Proffered Paper session 1
Resources:
Abstract
Slides
Webcast
Invited Discussant 64O and 65O
Presenter: Jarushka Naidoo
Session: Proffered Paper session 1
Resources:
Slides
Webcast
Q&A
Presenter: All Speakers
Session: Proffered Paper session 1
Resources:
Webcast
Welcome to the ESMO Immuno-Oncology Congress 2023
Presenter: Michele Maio
Session: Opening session and 2023 Award
Resources:
Slides
Webcast
Introduction to the 2023 Award keynote lecture
Presenter: Aurelien Marabelle
Session: Opening session and 2023 Award
Resources:
Slides
Webcast